Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (11-20 of 270) with videos related to

Pageof 27
Sort By:
Drugs|December 13, 2005
Potent gastric acid inhibition in the management of Barrett's oesophagusAngel Lanas
Gastroenterologia Y Hepatologia|December 17, 2009
[Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?]Angel Lanas
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin, cancer, and bleeding: an equation to solveAngel Lanas
Revista De Gastroenterologia De Mexico|March 16, 2005
[Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy]Angel Lanas
Nature Clinical Practice. Gastroenterology & Hepatology|October 18, 2007
Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?Angel Lanas
Medicina Clinica|February 28, 2002
[Gastrointestinal and cardiovascular side effects associated with COX-2 selective inhibitors]Angel Lanas
Expert Opinion on Drug Safety|July 22, 2010
Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practiceAngel Lanas
Rheumatology (Oxford, England)|April 22, 2010
A review of the gastrointestinal safety data--a gastroenterologist's perspectiveAngel Lanas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Compliance with prescriptions of appropriate therapy for nonsteroidal anti-inflammatory drug users: is the glass half empty or half full?Angel Lanas
The American Journal of Gastroenterology|January 8, 2010
Editorial: Upper GI bleeding-associated mortality: challenges to improving a resistant outcomeAngel Lanas
Pageof 27

Showing results (11-20 of 270) with videos related to

Sort By:
Pageof 27
Drugs|December 13, 2005
Potent gastric acid inhibition in the management of Barrett's oesophagusAngel Lanas
Gastroenterologia Y Hepatologia|December 17, 2009
[Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?]Angel Lanas
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin, cancer, and bleeding: an equation to solveAngel Lanas
Revista De Gastroenterologia De Mexico|March 16, 2005
[Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy]Angel Lanas
Nature Clinical Practice. Gastroenterology & Hepatology|October 18, 2007
Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?Angel Lanas
Medicina Clinica|February 28, 2002
[Gastrointestinal and cardiovascular side effects associated with COX-2 selective inhibitors]Angel Lanas
Expert Opinion on Drug Safety|July 22, 2010
Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practiceAngel Lanas
Rheumatology (Oxford, England)|April 22, 2010
A review of the gastrointestinal safety data--a gastroenterologist's perspectiveAngel Lanas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Compliance with prescriptions of appropriate therapy for nonsteroidal anti-inflammatory drug users: is the glass half empty or half full?Angel Lanas
The American Journal of Gastroenterology|January 8, 2010
Editorial: Upper GI bleeding-associated mortality: challenges to improving a resistant outcomeAngel Lanas
Pageof 27